I disagree and find it rather interesting that with Bavi in Phase III and in combination trial with a BP Drug no less- and in relation to sabatoged data- how much flack PPHM's BOD receives.
While I concur with the PPS movement - beyond a partnership there isn't much the BOD could do about the markets reaction to the Phase II debacle. Bring a BP partnership before or after SUNRISE results and many wounds will heal.